These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9223154)
1. Characterization of a secreted antigen of Onchocerca volvulus with host-protective potential. Jenkins RE; Taylor MJ; Gilvary N; Bianco AE Parasite Immunol; 1996 Jan; 18(1):29-42. PubMed ID: 9223154 [TBL] [Abstract][Full Text] [Related]
2. Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis. Taylor MJ; Abdel-Wahab N; Wu Y; Jenkins RE; Bianco AE Infect Immun; 1995 Nov; 63(11):4417-22. PubMed ID: 7591079 [TBL] [Abstract][Full Text] [Related]
3. OvB20, an Onchocerca volvulus-cloned antigen selected by differential immunoscreening with vaccination serum in a cattle model of onchocerciasis. Abdel-Wahab N; Kuo YM; Wu Y; Tuan RS; Bianco AE Mol Biochem Parasitol; 1996; 76(1-2):187-99. PubMed ID: 8920006 [TBL] [Abstract][Full Text] [Related]
4. The Secreted Larval Acidic Proteins (SLAPs) of Onchocerca spp. are encoded by orthologues of the alt gene family of Brugia malayi and have host protective potential. Wu Y; Egerton G; Pappin DJ; Harrison RA; Wilkinson MC; Underwood A; Bianco AE Mol Biochem Parasitol; 2004 Apr; 134(2):213-24. PubMed ID: 15003841 [TBL] [Abstract][Full Text] [Related]
5. Stage-specific and species cross-reactive antibody responses in experimental Onchocerca infections of cattle. Kuo YM; Bianco AE Am J Trop Med Hyg; 1995 Dec; 53(6):624-32. PubMed ID: 8561265 [TBL] [Abstract][Full Text] [Related]
6. Protective immunity induced by vaccination with Onchocerca volvulus tropomyosin in rodents. Taylor MJ; Jenkins RE; Bianco AE Parasite Immunol; 1996 May; 18(5):219-25. PubMed ID: 9229374 [TBL] [Abstract][Full Text] [Related]
7. Immunity to Onchocerca spp. in animal hosts. Abraham D; Lucius R; Trees AJ Trends Parasitol; 2002 Apr; 18(4):164-71. PubMed ID: 11998704 [TBL] [Abstract][Full Text] [Related]
8. Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans. George PJ; Hess JA; Jain S; Patton JB; Zhan T; Tricoche N; Zhan B; Bottazzi ME; Hotez PJ; Abraham D; Lustigman S PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007730. PubMed ID: 31525197 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the heat-shock protein 60 chaperonin from Onchocerca volvulus. Wu Y; Egerton G; Ball A; Tanguay RM; Bianco AE Mol Biochem Parasitol; 2000 Apr; 107(2):155-68. PubMed ID: 10779593 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis. Mahalakshmi N; Aparnaa R; Ansel Vishal L; Kaliraj P Parasitol Res; 2013 Sep; 112(9):3203-11. PubMed ID: 23828189 [TBL] [Abstract][Full Text] [Related]
11. Ov-ASP-1, the Onchocerca volvulus homologue of the activation associated secreted protein family is immunostimulatory and can induce protective anti-larval immunity. MacDonald AJ; Tawe W; Leon O; Cao L; Liu J; Oksov Y; Abraham D; Lustigman S Parasite Immunol; 2004 Jan; 26(1):53-62. PubMed ID: 15198646 [TBL] [Abstract][Full Text] [Related]
12. Successful vaccination against Onchocerca ochengi infestation in cattle using live Onchocerca volvulus infective larvae. Achukwi MD; Harnett W; Enyong P; Renz A Parasite Immunol; 2007 Mar; 29(3):113-6. PubMed ID: 17266738 [TBL] [Abstract][Full Text] [Related]
13. Characterisation of an immunodominant glycoprotein antigen of Onchocerca volvulus with homologues in other filarial nematodes and Caenorhabditis elegans. Tree TI; Gillespie AJ; Shepley KJ; Blaxter ML; Tuan RS; Bradley JE Mol Biochem Parasitol; 1995 Feb; 69(2):185-95. PubMed ID: 7770083 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a highly immunogenic calponin-like protein. Irvine M; Huima T; Prince AM; Lustigman S Mol Biochem Parasitol; 1994 May; 65(1):135-46. PubMed ID: 7935620 [TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of Ov-47, a dominant antigen of Onchocerca volvulus. Ghogomu SM; Souopgui J; Pelle R; Titanji VP Exp Parasitol; 2002 Mar; 100(3):143-9. PubMed ID: 12173398 [TBL] [Abstract][Full Text] [Related]
16. Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1. Joseph GT; Huima T; Lustigman S Mol Biochem Parasitol; 1998 Oct; 96(1-2):177-83. PubMed ID: 9851616 [No Abstract] [Full Text] [Related]
17. The Onchocerca volvulus cysteine proteinase inhibitor, Ov-CPI-2, is a target of protective antibody response that increases with age. Cho-Ngwa F; Liu J; Lustigman S PLoS Negl Trop Dis; 2010 Aug; 4(8):e800. PubMed ID: 20808763 [TBL] [Abstract][Full Text] [Related]
18. DNA immunisation with Onchocerca volvulus chitinase induces partial protection against challenge infection with L3 larvae in mice. Harrison RA; Wu Y; Egerton G; Bianco AE Vaccine; 1999 Nov; 18(7-8):647-55. PubMed ID: 10547424 [TBL] [Abstract][Full Text] [Related]
19. Onchocera volvulus: characterization of a highly immunogenic Gln-rich protein. Joseph GT; McCarthy JS; Huima T; Mair KF; Kass PH; Boussinesq M; Goodrick L; Bradley JE; Lustigman S Mol Biochem Parasitol; 1997 Dec; 90(1):55-68. PubMed ID: 9497032 [TBL] [Abstract][Full Text] [Related]
20. Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. McCarthy JS; Wieseman M; Tropea J; Kaslow D; Abraham D; Lustigman S; Tuan R; Guderian RH; Nutman TB Infect Immun; 2002 Feb; 70(2):851-8. PubMed ID: 11796620 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]